Released Jun 15, 2015, after the close
10-Q filed Jun 15, 2015, 46 days after period end · 0001354488-15-002996
Q2 2015 · 10-Q
Revenue—
Net Income$359.01K$359.01K +9.5% vs Q2 2014+24.5% vs Q1 2015
EPS Diluted$0.02$0.02 +7.1% vs Q2 2014+25.0% vs Q1 2015
Gross Profit$1,686,031−19.3%
Operating Income$391,992−6.5%
Operating Cash Flow-$568,002N/M
Free Cash Flowderived-$601,747N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2015 | Q2 2014 | Q2 2013 | Q2 2012 |
|---|---|---|---|---|
| Net Income | $359.01K | $327.78K | $1.39M | $1.19M |
| EPS Diluted | $0.02 | $0.01 | $0.06 | $0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pharma-Bio Serv, Inc. · CIK 1304161 · Engraved from SEC EDGAR